5-Amino-1MQ
A fat loss compound that blocks the NNMT enzyme to boost metabolism. 5-Amino-1MQ is a small molecule that inhibits NNMT (nicotinamide N-methyltransferase), an enzyme linked to fat accumulation and metabolic dysfunction. By blocking NNMT, it may increase NAD+ levels, boost cellular energy, promote fat loss, and support metabolic health. Studied for obesity, type 2 diabetes, and longevity applications.
Compare Prices🧬Key Characteristics
- Type: Small molecule(Not a peptide, but a quinolinium derivative.)
- Target: NNMT enzyme(Blocks nicotinamide N-methyltransferase.)
- Effect: NAD+ increase(May boost cellular energy metabolism.)
- Administration: Oral/Injectable(Small molecule allows oral dosing.)
Overview
Core Benefits
Key AdvantagesThese are educational summaries of commonly discussed effects in wellness/regenerative contexts, not guarantees.
5-Amino-1MQ Results Timeline
ProgressionTimeline is illustrative and non-guaranteed. Outcomes vary and are commonly discussed alongside training, nutrition, sleep, and cycling practices.
How It Works
Small Molecule — NNMT Inhibitor (Not a Peptide)Enzyme Target → NAD+ Preservation → Fat Metabolism → Outcomes
NNMT (Nicotinamide N-Methyltransferase)
5-Amino-1MQ inhibits NNMT, an enzyme that increases in fat tissue and contributes to metabolic dysfunction. NNMT degrades SAM (S-adenosylmethionine) and depletes NAD+ — blocking it preserves these critical metabolic cofactors.
NNMT Inhibition → NAD+ Preservation + SAM Protection
By blocking NNMT, 5-Amino-1MQ preserves NAD+ levels (critical for cellular energy production) and SAM (needed for methylation reactions). This shifts cellular metabolism toward fat oxidation and away from fat storage, particularly in adipose tissue.
Enhanced Fat Metabolism + Cellular Energy
Reduced fat accumulation, enhanced fat oxidation, and improved cellular energy production through preserved NAD+. May also reduce inflammation in fat tissue. Orally bioavailable — no injection required.
Gradual Fat Loss → Improved Energy → Metabolic Health
Effects are gradual — fat loss and metabolic improvements over weeks. More subtle than GLP-1 agonists but works through a completely different mechanism. Can be combined with other fat-loss approaches for complementary effects.
What Makes This Peptide Different
5-Amino-1MQ is not a peptide — it's a small molecule that inhibits NNMT. Its unique mechanism (preserving NAD+ and SAM) complements rather than overlaps with GLP-1 agonists or GH peptides. Oral bioavailability means no injections. The NAD+-preserving effect may have broader longevity implications beyond fat loss.
Dosing Protocol
Fat Loss / Metabolic HealthEducational reference only. Individual responses vary. Consult healthcare provider before use.
Why This Dosing Protocol
Why oral? 5-Amino-1MQ has good oral bioavailability as a small molecule. Capsules are the standard delivery method. Injectable versions exist but aren't necessary for most.
Why morning? Aligning with the body's active metabolic period. Supports fat oxidation throughout the day.
Diagrams
Hover for preview • Click to open full size
5-Amino-1MQ Pricing
We surface in-stock offers first and normalize by price per mg for quick comparisons.
5 mg / vial
In-stock offers50 mg / vial
In-stock offersLooking for medical guidance?
Join the waitlist for doctor-guided peptide plans. We'll notify you when telehealth consultations are available in your state.
FAQ
Is 5-Amino-1MQ actually a peptide?
No, 5-Amino-1MQ is technically a small molecule, not a peptide. It's a methylquinolinium derivative that inhibits the NNMT enzyme. However, it's commonly discussed alongside peptides because it's sold through similar research chemical channels and targets metabolic pathways relevant to the peptide community.
How does 5-Amino-1MQ differ from other fat loss compounds?
Unlike stimulant-based fat burners or thyroid modulators, 5-Amino-1MQ works by inhibiting NNMT (nicotinamide N-methyltransferase), an enzyme that's overexpressed in fat tissue. This unique mechanism may increase NAD+ levels and activate sirtuins, potentially improving metabolic health rather than just increasing calorie burn. It doesn't typically cause jitteriness or affect heart rate like stimulants.
What is NNMT and why does inhibiting it matter?
NNMT (nicotinamide N-methyltransferase) is an enzyme that becomes overactive in obesity. It consumes NAD+ precursors, which can deplete cellular energy metabolism. By inhibiting NNMT, 5-Amino-1MQ may help restore NAD+ levels, activate longevity-related sirtuins, reduce fat accumulation, and improve insulin sensitivity. NNMT is particularly elevated in visceral fat and liver tissue.
Can 5-Amino-1MQ be taken orally?
Yes, one advantage of 5-Amino-1MQ being a small molecule rather than a peptide is that it has oral bioavailability. Unlike most peptides which require injection, 5-Amino-1MQ can potentially be absorbed through the digestive system, making it more convenient for research applications.
How does 5-Amino-1MQ relate to NAD+ and longevity research?
5-Amino-1MQ connects to longevity research through the NAD+ pathway. By inhibiting NNMT, it may preserve NAD+ levels, which naturally decline with age. NAD+ is essential for sirtuins (like SIRT1) which regulate metabolism, cellular repair, and aging processes. This makes 5-Amino-1MQ relevant to both metabolic health and anti-aging research.
Scientific Sources
The following peer-reviewed studies and official resources provide additional scientific context for this peptide:
Disclosure: we may earn affiliate commission from qualifying purchases. Educational information only — not medical advice.